Kestra Advisory Services’s KALA BIO KALA Stock Holding History

Kestra Advisory Services’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5	Closed	-$3K	–	2294
2022 Q3	$3K	Buy	5 +1	+25%	+$785	﹤0.01%	2098
2022 Q2	$3K	Hold	4	–	–	﹤0.01%	2127
2022 Q1	$14K	Hold	4	–	–	﹤0.01%	1987
2021 Q4	$12K	Hold	4	–	–	﹤0.01%	2003
2021 Q3	$26K	Hold	4	–	–	﹤0.01%	2099
2021 Q2	$53K	Hold	4	–	–	﹤0.01%	1975
2021 Q1	$67K	Hold	4	–	–	﹤0.01%	1816
2020 Q4	$69K	Buy	+4	New	+$75.3K	﹤0.01%	1804

Other funds holding KALA

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Kestra Advisory Services's KALA Position: Q4 2022 in Review

Kestra Advisory Services sold out of KALA BIO (KALA) in Q4 2022, closing a stake of 5 shares — an estimated $3K sold.

Kestra Advisory Services first reported a position in KALA in Q4 2020 and held it in 8 quarters. The position peaked at $69K in Q4 2020. 28 funds tracked by Wall St. Rank hold KALA as of Q4 2022.

Kestra Advisory Services reported no remaining KALA BIO position as of Q4 2022 after selling out during the quarter.
Kestra Advisory Services sold 5 KALA BIO shares in Q4 2022, an estimated $3K.
Kestra Advisory Services first reported a position in KALA BIO in Q4 2020 and held it in 8 quarters.
Kestra Advisory Services's KALA BIO position peaked at $69K in Q4 2020.
28 funds tracked by Wall St. Rank held KALA BIO as of Q4 2022.

Based on Kestra Advisory Services's 13F filing for Q4 2022, filed 31 Jan 2023.